November 23, 2014

   A Publication of the James Buchanan Brady
   Urological Institute Johns Hopkins Medical Institutions

Volume II, Winter 1991

BIBLIOGRAPHY

  1. Oesterling, J.E., Chan, D.W., Epstein, J.I., Kimball Jr., A.W., Bruzek, D.J., Rock, R.C., Brendler, C.B., and Walsh, P.C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol. 139: 766-772, 1988.
  2. Epstein, J.I., Oesterling, J.E., and Walsh, P.C.: Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. J. Urol. 139:980-984,1988.
  3. Epstein, J.I., Oesterling, J.E., and Walsh, P.C.: The volume and anatomical location of residual tumor in radical prostatectomy s pecimens removed for stage A1 prostate cancer. J. Urol. 139:975-979, 1988.
  4. Walsh, P.C., Schlegel, P.N.: Radical pelvic surgery with preservation of sexual function. Ann. Surg. and Transactions of the American Surgical Association, 106:145-154, Oct. 1988.
  5. Walsh, P.C.: Nerve-Sparing Radical Prostatectomy for Early Stage Prostate Cancer. In Seminars in Oncology, Vol. 15, (ed) Marc B. Garnick, Grune & Stratton, 1988, pp. 351-358.
  6. Walsh, P.C.: Radical retropubic prostatectomy with reduced morbidity: An anatomic approach. NCI Monographs, #7:133-137, 1988.
  7. Lepor, H. and Walsh, P.C.: Longterm results of radical prostatectomy in clinically localized prostate cancer: experience at The Johns Hopkins Hospital. NCI Monograph #7:117-122, 1988.
  8. Lepor, H., Kimball, A.W., and Walsh, P.C.: Cause-specific actuarial survival analysis: A useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J. Urol. 141:82-84, 1989.
  9. Partin, A.W., Epstein, J.I., Cho, K.R., Gittelsohn, A.M. and Walsh, P.C.: Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J. Urol. 141:34 1 345, 1989.
  10. Quinlan, D.M., Nelson, R.J., Partin, A.W., Mostwin, J.L. and Walsh, P.C.: The rat as a model for the study of penile erection. J. Urol. 141:656-661, 1989.
  11. Weber, J.P., Oesterling, J.E., Peters, C.A., Partin, A.W., Chan, D.W., and Walsh, P.C.: The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J. Urol. 141:987-992, 1989.
  12. Walsh, P.C., Oesterling, J.E., Epstein, J.I., Bruzek, D.J., Rock R.C., and Chan, D.W.: The value of prostate-specific antigen in the management of localized prostatic cancer. In Therapeutic Progress in Urological Cancers, (eds) Gerald P. Murphy and Saad Khoury, Alan R. Liss, Inc., New York, 1989, pp. 27-33.
  13. Alexander, R.B., Maguire, M.G., Epstein, J.I., and Walsh, P.C.: Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate. J. Urol. 141:880-882, 1989.
  14. Schlegel, P.N. and Walsh, P.C.: The use of the preperitoneal approach for the simultaneous repair of inguinal hernia during surgery on the bladder and prostate. World J. Surg. 13:555-559, 1989.
  15. Carter, H.B., Hamper, U.M., Sheth, S., Sanders, R.C., Epstein, J.I., and Walsh, P.C.: Evaluation of transrectal ultrasound in the early detection of prostate cancer. J. Urol. 142:1008-1010, 1989.
  16. Christensen, W.N., Partin, A.W., Walsh, P.C., and Epstein, J.I.: Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage. Cancer 65:1021-1027, 1990.
  17. Walsh, P.C., Brendler, C.B., Chang, T., Marshall, F.F., Mostwin, J.1., Stutzman, R., and Schlegel, P.N.: Preservation of sexual function in men during radical pelvic surgery. MMJ 39:389-393, April 1990
  18. Partin, A.W., Carter, H.B., Chan, D.W., Epstein, J.I., Oesterling, J.E., Rock, R.C., Weber, J. P., and Walsh, P.C.: Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol. 143:747752, 1990.
  19. Steinberg, G.D., Epstein, J.I., Piantadosi, S., & Walsh, P.C.: Management of stage D1 adenocarcinoma of the prostate: The Johns Hopkins Experience 1974-1987. J. Urol. (in press).
  20. Partin, A.W., Oesterling, J.E., Epstein, J.I., Horton, R., & Walsh, P.C.; Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J. Urol. (in press).
  21. Walsh, P.C., Quinlan, DM., Mortoti, R.A., and Steiner, M.S.: Radical retropubic prostatectomy: Improved anastomosis and urinary continence. Urol. Clin. N. Amer. 17:679-684, 1990.
  22. Steiner, M.S., Morton, R.A., and Walsh, P.C.: Impact of anatomical radical prostatectomy on urinary continence. J. Urol. (in press). 23. Quinlan, D.M., Epstein, J.I., Carter, B.S., and Walsh, P.C.: Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. J. Urol. (in press)
  23. Morton, R.A., Steiner, M.S., and Walsh, P.C.: Cancer control following anatomical radical prostatectomy: An interim report. J. Urol. (in press).
  24. Brendler, C.B., Steinberg, G.D., Marshall, F.F., Mostwin, J.I., and Walsh, P.C.: Local recurrence and survival following nerve-sparing radical cystoprostatectcomy. J. Urol. (in press).
  25. Marshall, F.F., Mostwin, J.I., Radebaugh, L., Walsh, P.C., and Brendier, C.B.: Ileocolic neobladder postcystectomy: continence and potency. (Submitted for publication).
  26. Rifkin, M.D., Zerhouni, E.A., Gatsonis, C.A., Quint, L.E., Paushter, DM., Epstein, J.I., Hamper, U., Walsh, P.C., and McNeil, B.J.: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. NEJM 323:2- 7, 1990.
 

© Copyright 2014 | All Rights Reserved | Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287